A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

NCT03708211 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Advanced Solid

Interventions

DRUG: TAK-931 PIC
DRUG: TAK-931 Tablet
DRUG: Esomeprazole

Sponsor

Millennium Pharmaceuticals, Inc.